| # | Drug | Count |
|---|---|---|
| 0 | SILDENAFIL CITRATE | 48 |
| 1 | BOSENTAN | 42 |
| 2 | EPOPROSTENOL | 30 |
| 3 | SILDENAFIL | 30 |
| 4 | MACITENTAN | 25 |
| 5 | TREPROSTINIL | 25 |
| 6 | TADALAFIL | 22 |
| 7 | AMBRISENTAN | 21 |
| 8 | SILDENAFIL POWDER, | 21 |
| 9 | FUROSEMIDE | 14 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | EPOPROSTENOL | 30 | 0.0023 |
| 1 | BOSENTAN | 42 | 0.0008 |
| 2 | SILDENAFIL POWDER, | 21 | 0.0006 |
| 3 | NITRIC OXIDE | 2 | 0.0004 |
| 4 | SILDENAFIL CITRATE | 48 | 0.0004 |
| 5 | MACITENTAN | 25 | 0.0004 |
| 6 | LETERMOVIR | 1 | 0.0003 |
| 7 | DOPAMINE HYDROCHLORIDE | 1 | 0.0003 |
| 8 | DOBUTAMINE | 1 | 0.0003 |
| 9 | METHIMAZOLE | 2 | 0.0003 |
| # | Drug class | Count |
|---|---|---|
| 0 | Prostacycline Vasodilator [EPC] | 49 |
| 1 | Endothelin Receptor Antagonist [EPC] | 46 |
| 2 | Phosphodiesterase 5 Inhibitor [EPC] | 42 |
| 3 | Loop Diuretic [EPC] | 18 |
| 4 | Prostacyclin Receptor Agonist [EPC] | 6 |
| 5 | Aldosterone Antagonist [EPC] | 5 |
| 6 | Cardiac Glycoside [EPC] | 5 |
| 7 | Factor Xa Inhibitor [EPC] | 5 |
| 8 | Osmotic Laxative [EPC] | 4 |
| 9 | Potassium Salt [EPC] | 4 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Prostacycline Vasodilator [EPC] | 49 | 0.0004 |
| 1 | Phosphodiesterase 5 Inhibitor [EPC] | 42 | 0.0003 |
| 2 | Cytomegalovirus DNA Terminase Complex Inhibitor [EPC] | 1 | 0.0003 |
| 3 | Prostacyclin Receptor Agonist [EPC] | 6 | 0.0002 |
| 4 | Endothelin Receptor Antagonist [EPC] | 46 | 0.0002 |
| 5 | Thyroid Hormone Synthesis Inhibitor [EPC] | 2 | 0.0002 |
| 6 | Cannabinoid [EPC] | 1 | 0.0001 |
| 7 | Soluble Guanylate Cyclase Stimulator [EPC] | 4 | 0.0001 |
| 8 | Sulfone [EPC] | 1 | 0.0001 |
| 9 | Cardiac Glycoside [EPC] | 5 | 0.0001 |